Cancer Research Campaign Technology appoints CRV as exclusive agent

On 16th January 2001 Cancer Research Ventures (CRV) was appointed the exclusive agent of Cancer Research Campaign Technology (CRCT) for the purposes of conducting all new technology transfer business derived from research funded by The Cancer Research Campaign (The CRC).

The addition of the rich source of cancer technologies emanating from The CRC, expands CRV’s technology transfer and development business to include the majority of UK cancer funders as well as including many clients in Europe. CRV will also be strengthened by the addition of the staff and assets of CRCT to the CRV operations.